149 related articles for article (PubMed ID: 10404060)
1. High frequency of inactivation of the imprinted H19 gene in "sporadic" hepatoblastoma.
Fukuzawa R; Umezawa A; Ochi K; Urano F; Ikeda H; Hata J
Int J Cancer; 1999 Aug; 82(4):490-7. PubMed ID: 10404060
[TBL] [Abstract][Full Text] [Related]
2. Biallelic expression of the H19 and IGF2 genes in hepatocellular carcinoma.
Kim KS; Lee YI
Cancer Lett; 1997 Nov; 119(2):143-8. PubMed ID: 9570364
[TBL] [Abstract][Full Text] [Related]
3. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting.
Li X; Adam G; Cui H; Sandstedt B; Ohlsson R; Ekström TJ
Oncogene; 1995 Jul; 11(2):221-9. PubMed ID: 7624139
[TBL] [Abstract][Full Text] [Related]
4. Loss of imprinting of IGF2 correlates with hypermethylation of the H19 differentially methylated region in hepatoblastoma.
Honda S; Arai Y; Haruta M; Sasaki F; Ohira M; Yamaoka H; Horie H; Nakagawara A; Hiyama E; Todo S; Kaneko Y
Br J Cancer; 2008 Dec; 99(11):1891-9. PubMed ID: 19034281
[TBL] [Abstract][Full Text] [Related]
5. Loss of imprinting in hepatoblastoma.
Rainier S; Dobry CJ; Feinberg AP
Cancer Res; 1995 May; 55(9):1836-8. PubMed ID: 7728748
[TBL] [Abstract][Full Text] [Related]
6. Variable imprinting of H19 and IGF2 in fetal cerebellum and medulloblastoma.
Albrecht S; Waha A; Koch A; Kraus JA; Goodyer CG; Pietsch T
J Neuropathol Exp Neurol; 1996 Dec; 55(12):1270-6. PubMed ID: 8957451
[TBL] [Abstract][Full Text] [Related]
7. p57(KIP2) is not mutated in hepatoblastoma but shows increased transcriptional activity in a comparative analysis of the three imprinted genes p57(KIP2), IGF2, and H19.
Hartmann W; Waha A; Koch A; Goodyer CG; Albrecht S; von Schweinitz D; Pietsch T
Am J Pathol; 2000 Oct; 157(4):1393-403. PubMed ID: 11021841
[TBL] [Abstract][Full Text] [Related]
8. Multipoint analysis of human chromosome 11p15/mouse distal chromosome 7: inclusion of H19/IGF2 in the minimal WT2 region, gene specificity of H19 silencing in Wilms' tumorigenesis and methylation hyper-dependence of H19 imprinting.
Dao D; Walsh CP; Yuan L; Gorelov D; Feng L; Hensle T; Nisen P; Yamashiro DJ; Bestor TH; Tycko B
Hum Mol Genet; 1999 Jul; 8(7):1337-52. PubMed ID: 10369881
[TBL] [Abstract][Full Text] [Related]
9. Chromosome 11p15.5 regional imprinting: comparative analysis of KIP2 and H19 in human tissues and Wilms' tumors.
Chung WY; Yuan L; Feng L; Hensle T; Tycko B
Hum Mol Genet; 1996 Aug; 5(8):1101-8. PubMed ID: 8842727
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of H19, an imprinted and putative tumor repressor gene, is a preneoplastic event during Wilms' tumorigenesis.
Cui H; Hedborg F; He L; Nordenskjöld A; Sandstedt B; Pfeifer-Ohlsson S; Ohlsson R
Cancer Res; 1997 Oct; 57(20):4469-73. PubMed ID: 9377554
[TBL] [Abstract][Full Text] [Related]
11. H19 and IGF-2 allele-specific expression in hepatoblastoma.
Ross JA; Radloff GA; Davies SM
Br J Cancer; 2000 Feb; 82(4):753-6. PubMed ID: 10732739
[TBL] [Abstract][Full Text] [Related]
12. Disruption of imprinted genes at chromosome region 11p15.5 in paediatric rhabdomyosarcoma.
Anderson J; Gordon A; McManus A; Shipley J; Pritchard-Jones K
Neoplasia; 1999 Oct; 1(4):340-8. PubMed ID: 10935489
[TBL] [Abstract][Full Text] [Related]
13. Pediatric adrenocortical tumors: molecular events leading to insulin-like growth factor II gene overexpression.
Wilkin F; Gagné N; Paquette J; Oligny LL; Deal C
J Clin Endocrinol Metab; 2000 May; 85(5):2048-56. PubMed ID: 10843195
[TBL] [Abstract][Full Text] [Related]
14. Genomic imprinting of IGF2 and H19 in human meningiomas.
Müller S; Zirkel D; Westphal M; Zumkeller W
Eur J Cancer; 2000 Mar; 36(5):651-5. PubMed ID: 10738131
[TBL] [Abstract][Full Text] [Related]
15. Imprinting of IGF2 and H19: lack of reciprocity in sporadic Beckwith-Wiedemann syndrome.
Joyce JA; Lam WK; Catchpoole DJ; Jenks P; Reik W; Maher ER; Schofield PN
Hum Mol Genet; 1997 Sep; 6(9):1543-8. PubMed ID: 9285792
[TBL] [Abstract][Full Text] [Related]
16. High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19.
Douc-Rasy S; Barrois M; Fogel S; Ahomadegbe JC; Stéhelin D; Coll J; Riou G
Oncogene; 1996 Jan; 12(2):423-30. PubMed ID: 8570220
[TBL] [Abstract][Full Text] [Related]
17. Maintenance of normal imprinting of H19 and IGF2 genes in neuroblastoma.
Wada M; Seeger RC; Mizoguchi H; Koeffler HP
Cancer Res; 1995 Aug; 55(15):3386-8. PubMed ID: 7614476
[TBL] [Abstract][Full Text] [Related]
18. Igf2 imprinting does not require its own DNA methylation or H19 RNA.
Jones BK; Levorse JM; Tilghman SM
Genes Dev; 1998 Jul; 12(14):2200-7. PubMed ID: 9679064
[TBL] [Abstract][Full Text] [Related]
19. Loss of imprinting and loss of heterozygosity on 11p15.5 in head and neck squamous cell carcinomas.
Rainho CA; Kowalski LP; Rogatto SR
Head Neck; 2001 Oct; 23(10):851-9. PubMed ID: 11592232
[TBL] [Abstract][Full Text] [Related]
20. Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site.
Cui H; Niemitz EL; Ravenel JD; Onyango P; Brandenburg SA; Lobanenkov VV; Feinberg AP
Cancer Res; 2001 Jul; 61(13):4947-50. PubMed ID: 11431321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]